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The exogenous lipoic acid (LA) is successfully used as a drug in the treatment of many diseases. It is assumed that after
administration, LA is transported to the intracellular compartments and reduced to dihydrolipoic acid (DHLA) which is
catalyzed by NAD(P)H-dependent enzymes. The purpose of this study was to investigate whether LA can attenuate
cardiovascular disturbances induced by ethanol (EtOH) and disulfiram (DSF) administration separately or jointly in rats. For
this purpose, we measured systolic and diastolic blood pressure, recorded electrocardiogram (ECG), and estimated
mortality of rats. We also studied the activity of aldehyde dehydrogenase (ALDH) in the rat liver. It was shown for the
first time that LA partially attenuated the cardiac arrhythmia (extrasystoles and atrioventricular blocks) induced by EtOH and
reduced the EtOH-induced mortality of animals, which suggests that LA may have a potential for use in cardiac disturbance in
conditions of acute EtOH intoxication. The administration of EtOH, LA, and DSF separately or jointly affected the ALDH
activity in the rat liver since a significant decrease in the activity of the enzyme was observed in all treatment groups. The results
indicating that LA is an inhibitor of ALDH activity are very surprising.
1. Introduction
According to the World Health Organization (WHO) in
2016, the alcohol abuse resulted in 3 million deaths (5.3%
of all deaths) worldwide and 132.6 million disability-
adjusted life years (DALYs), i.e., 5.1% of all DALYs in that
year [1]. DALYs are the sum of years of life lost due to prema-
ture mortality as well as years of life lost due to time lived in
less than full health.
According to the authors of that report, the cardiovascu-
lar diseases (CVDs) are the leading cause of mortality glob-
ally, causing 17.9 million deaths (31.6% of all deaths) and
413.2 million DALYs (15.9% of all DALYs). Globally in
2016, alcohol caused an estimated net CVD burden of
593 000 deaths (3.3% of all CVD deaths) and 13 million
CVD DALYs (3.2% of all CVD DALYs). CVDs were
responsible for 19.8% and 9.8% of all alcohol-attributable
deaths and DALYs lost, respectively [1].
Metabolism of ethanol (EtOH) in the human body occurs
mainly in the liver. EtOH can be oxidized to acetaldehyde by
three routes: (1) in the presence of NAD in the reversible
reaction catalyzed by alcohol dehydrogenase (ADH; E.C
1.1.1.1), (2) in the presence of NADPH andmolecular oxygen
(O2) in the reaction catalyzed by microsomal ethanol oxi-
dizing system (MEOS), and (3) in the presence of hydro-
gen peroxide (H2O2) in the reaction catalyzed by catalase
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(EC 1.11.1.6). ADH is themain enzyme in EtOHmetabolism.
This enzyme oxidizes 92–96% of the ingested alcohol [2].
C2H5OH +NAD+ ⟷
ADH
CH3CHO +NADH +H+
C2H5OH +NADPH +H+ +O2 !MEOS CH3CHO +NADP+ + 2H2O
C2H5OH +H2O2 !catalase CH3CHO + 2H2O
ð1Þ
The second step of EtOH metabolism is catalyzed by
aldehyde dehydrogenase (ALDH; E.C 1.2.1.3). This enzyme
converts acetaldehyde to acetic acid which can be involved
in a number of metabolic processes within the organism.
CH3CHO +NAD+ !ALDH CH3COOH +NADH +H+ ð2Þ
Disulfiram (tetraethylthiuram disulfide, antabuse, or
DSF) is a well-known inhibitor of ALDH. By inhibiting
ALDH activity, DSF causes EtOH intolerance due to poi-
soning with acetaldehyde, the concentration of which is
high after EtOH consumption. It means that EtOH intake
during DSF treatment results in the accumulation of acet-
aldehyde, which is associated with a risk of severe often
life-threatening cardiovascular disturbances, including car-
diac arrhythmia, drop in blood pressure, circulatory collapse,
and death. These unpleasant and potentially life-threatening
symptoms are known as DSF-EtOH reaction (DER). Of
course, it is known that intoxication by excessive EtOH con-
sumption alone (without DSF) can also cause death due to
hypotonia and cardiovascular failure [3].
Therefore, it appears that it is justified to search for drugs
capable of attenuating toxicity of EtOH alone and preventing
or halting the progression of the DER/DSF-like reactions. We
wished to examine whether lipoic acid (LA, 5-[(3R)-dithio-
lan-3-yl]pentanoic acid) would be able to attenuate cardio-
vascular disturbances induced by EtOH and/or DSF. Why
LA? There are reports that LA is able to reduce myocardial
injury and preserve cardiac function during ischemia-
reperfusion injury [4, 5]. Many studies on animal models
have also confirmed that LA can prevent progressive remod-
eling and even improve cardiac function [6]. Dudek et al.
have indicated that LA protects the heart against myocardial
post ischemia-reperfusion arrhythmias via KATP channel
activation in isolated rat hearts [7]. The experimental study
of Sokołowska et al. has proven a beneficial effect of LA on
cyanate toxicity in the rat heart [8]. Skibska et al. in their
excellent review indicated that although LA is used in various
diseases, it can be particularly effective in cardiovascular dis-
eases, including ischemic heart disease, hypertension, and
heart failure [9].
Thus, in this study, we hypothesized for the first time that
LA treatment can attenuate cardiovascular disturbances
induced by EtOH and DSF administration separately or
jointly in rats. For this purpose, systolic and diastolic blood
pressure were measured, electrocardiogram (ECG) was
recorded, and mortality of rats was estimated. Moreover,
the activity of ALDH in the rat liver was studied.
2. Materials and Methods
2.1. Reagents. In this study, the formulation Thiogamma was
used, which contains LA as the pharmacologically active
substance. Thiogamma was obtained from Hexal®AG,
(Holzkirchen, Germany). Thiopental sodium was obtained
fromHEFA-Freon Arzneimittel (Germany). Heparin sodium
was obtained from Polfa S.A. (Poland). Disulfiram, EDTA,
Folin-Ciocalteau reagent, 4-methylpyrazole, NAD, propio-
naldehyde, and rotenone were provided by Sigma-Aldrich
Chemical Company (Poznań, Poland). All other reagents
were of analytical grade and were obtained from Polish
Chemical Reagent Company (POCh, Gliwice, Poland).
2.2. Animals and In Vivo Treatment. All procedures were
performed according to the Animal Use and Care Committee
Guidelines and were approved by the Ethics Committee of
the Jagiellonian University, Kraków, Poland (registration
number 106/2009 and ZI/UJ/403/2007). The experiments
were carried out on male Wistar rats (180–200 g). Animals
were housed in plastic cages in a room at a constant temper-
ature of 20 ± 2°C with a natural light-dark cycle. They had
free access to standard pellet diet and water. The tested com-
pounds were administered at doses calculated per kg body
weight (bw). EtOH was given by a gavage, and LA and DSF
by intraperitoneal (IP) injection. The control group was
injected IP with 0.6ml of saline (0.9% NaCl).
2.3. Blood Pressure. The rats were anesthetized by IP injection
of thiopental (70mg/kg). The left carotid artery was cannu-
lated with polyethylene tubing filled with heparin solution
in saline to facilitate pressure measurements using a Data-
max apparatus (Columbus Instruments, Ohio). The animals
were assigned to eight groups of 6 animals each. Blood pres-
sure was measured as follows:
(i) Group received 0.9% NaCl: measurement lasted
30min
(ii) EtOH group: measurement was conducted before
EtOH administration (2.5 g/kg) and was continued
for 30min thereafter
(iii) Group I (LA group): measurement was conducted
before LA administration (100mg/kg) and was
continued for 60min thereafter
(iv) Group II (DSF group): measurement was con-
ducted before DSF (100mg/kg) administration
and was continued for 60min thereafter
(v) Group III (DSF+LA group): measurement was con-
ducted before LA (100mg/kg) and DSF
(100mg/kg) administration and was continued for
60min thereafter
(vi) Group IV (LA+EtOH group): measurement was
conducted before LA administration (100mg/kg)
and was continued for 30min thereafter. In the
30th min, EtOH (2.5 g/kg) was administered and
the measurement was continued for the next
30min
2 Oxidative Medicine and Cellular Longevity
(vii) Group V (DSF+EtOH group): measurement was
conducted before DSF (100mg/kg) administration
and was continued for 30min thereafter. In the
30th min, EtOH (2.5 g/kg) was administered and
the measurement was continued for the next
30min
(viii) Group VI (LA+DSF+EtOH group): measurement
was conducted before LA (100mg/kg) and DSF
(100mg/kg) administration and was continued
30min thereafter. In the 30th min, EtOH (2.5 g/kg)
was administered and themeasurement was contin-
ued for the next 30min
Subsequently, animals were sacrificed. The livers were
removed, washed in 0.9% NaCl, placed in liquid nitrogen,
and stored at -80°C until biochemical tests were performed.
2.4. Electrocardiogram Recording (ECG). The rats were anes-
thetized by IP injection of thiopental at a dose of 70mg/kg.
The ECG was recorded with three needle electrodes placed
on the skin on the right and left chest and the left foot. Elec-
trocardiographic investigations were carried out using Multi-
card 30 apparatus, standard lead II, and paper speed of
50mm/s. The ECG was standardized before each tracing to
achieve appropriate sensitivity (2mV pulse produces
20mm height) and chart speed (50mm/s). The animals were
assigned to seven groups of 6 animals. ECG evaluated such
parameters as extrasystole, bradycardia, atrioventricular
blocks, and mortality. For each group, the percentage of ani-
mals, in which the disturbance occurred, was calculated.
(i) Group A (EtOH): the ECG recording started in the
1st min and ended in the 30th min after EtOH
administration (2.5 g/kg)
(ii) Group B (LA+EtOH): the ECG recording started in
the 1st min after LA administration (100mg/kg) and
was conducted for the next 30min. In the 30th min,
EtOH (2.5 g/kg) was administered; the ECG record-
ing ended in the 60th min after LA administration
(30min after EtOH administration)
(iii) Group C (LA): the ECG recording started in the 1st
min and ended in the 60th min after LA administra-
tion (100mg/kg)
(iv) Group D (DSF): the ECG recording started in the 1st
min and ended in the 60th min after DSF adminis-
tration (100mg/kg)
(v) Group E (LA+DSF group): the ECG recording
started in the 1st min and ended in 60th min after LA
(100mg/kg) and DSF (100mg/kg) administration
(vi) Group F (LA+DSF+EtOH group): the ECG record-
ing started in the 1st min after LA (100mg/kg) and
DSF (100mg/kg) administration and was con-
ducted for the next 30min. In the 30th min, EtOH
(2.5 g/kg) was administered. The recording of ECG
ended in the 60th min after LA and DSF administra-
tion (30min after EtOH administration)
(vii) Group G (DSF+EtOH group): the ECG recording
started in the 1stmin afterDSF (100mg/kg) adminis-
tration andwas conducted for the next 30min. In the
30th min, EtOH (2.5 g/kg) was administered. The
ECG recording ended in the 60th min after DSF
administration (30min after EtOH administration)
2.5. Determination of ALDH Activity in the Rat Liver
Homogenate. The assay mixture contained liver homog-
enate, sodium phosphate buffer (pH8.2), NAD, EDTA,
4-methylpyrazole, and rotenone. The reaction was initi-
ated by the addition of propionaldehyde as a substrate.
4-Methylpyrazole was added to inhibit alcohol dehydroge-
nase, and rotenone to inhibit mitochondrial NADH oxidase.
The blank sample without the homogenate or the substrate
was run simultaneously. The activity of ALDHwas calculated
by using the molar extinction coefficient of NADH of
6.22mM-1 cm-1 at 340 nmwith the use of a modified protocol
published earlier [10, 11]. Enzyme-specific activity was
expressed as nmol NADH min-1 mg-1 protein. The protein
content was determined by the method which is based
on the reaction of peptide bonds and aromatic amino acid
residues with Folin-Ciocalteau reagent (a mixture of phos-
photungstic and phosphomolybdic acids) in alkaline envi-
ronment in the presence of copper (II) ions. Protein
bound with copper ions reduces the above acids to respec-
tive oxides. Absorbance was measured at 500 nm [12].
2.6. Statistics. All statistical calculations were carried out with
the use of GraphPad Prism 6.0 computer program.
The results obtained from measurements of blood
pressure are presented as the mean ± SEM of animals in
each group. The statistical calculations were performed
using a two-way ANOVA Multiple Comparison and post
hoc Tukey test.
The results obtained from measurements of ALDH activ-
ity in rat liver homogenates are presented as the mean ± SD
for each group of animals. The statistical calculations were
performed using a one-way ANOVA and post hoc Tukey test.
For all data, the values of p < 0:05 were considered to be
statistically significant.
3. Results
3.1. The Effect of Ethanol Administration on Systolic and
Diastolic Blood Pressure in Rats. The blood pressure in rats,
which received 0.9% NaCl was 130.67/105.33mmHg at t = 0
measurement. The blood pressure was 105.33/103.67mmHg
measured at 30 minutes (t = 30) after administration of salt
(Figure 1).
EtOH administration caused a statistically significant
decrease only in diastolic blood pressure at 30 minutes of
measurement compared to the pressure measured before
the administration of EtOH, i.e., at t = 0 (Figure 1). Blood
pressure measured before EtOH administration (t = 0) was
122.67/99.33mmHg, while measured at 30min (t = 30)
amounted to 102.33/69.33mmHg (Figure 1).
3.2. The Effect of Lipoic Acid on the Systolic and Diastolic
Blood Pressure in Rats. Systolic blood pressure measured
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before administration of LA (t = 0) was 132.5mmHg, while
measured 60 minutes after administration of LA was
115.33mmHg. Statistically significant changes in systolic
blood pressure were observed from 30 minutes after admin-
istration of LA. This means that LA lowers systolic blood
pressure in rats. However, the effect of LA on the diastolic
blood pressure was not observed (Figure 2(a)).
3.3. The Effect of Disulfiram on the Systolic and Diastolic
Blood Pressure in Rats. DSF administration statistically sig-
nificantly decreased systolic and diastolic blood pressure in
rats. Blood pressure measured before DSF treatment (t = 0)
was 127.67/89.5mmHg while determined at 60 minutes
(t = 60) was 105/72mmHg. Statistically significant changes
in systolic and diastolic blood pressure were observed from
40th to 50th minute, respectively, after administration of
DSF. This means that DSF lowers blood pressure in rats
(Figure 2(b)).
3.4. The Effect of Combined Lipoic Acid and Disulfiram
Treatment on the Systolic and Diastolic Blood Pressure in
Rats. The combined LA and DSF treatment statistically sig-
nificantly reduced systolic and diastolic blood pressure in
rats. Blood pressure before joint administration of LA and
DSF (t = 0) was 123.6/95.33mmHg, while recorded at 60
minutes (t = 60) was 104.67/63.33mmHg (Figure 2(c)). Sta-
tistically significant changes in diastolic and systolic blood
pressure were observed from 10th to 15th minute, respec-
tively, after administration of LA and DSF.
This means that the combined administration of LA and
DSF lowers blood pressure in rats (Figure 2(c)).
3.5. The Effect of Combined Lipoic Acid and Ethanol
Treatment on the Systolic and Diastolic Blood Pressure in
Rats. The combined LA and EtOH treatment statistically
significantly reduced systolic and diastolic blood pressure
in rats. Blood pressure before administration of EtOH
was 118.33/93.67mmHg, while measured 30 minutes after
administration of EtOH was 111.5/81.5mmHg. However,
the pressure measured at t = 0 minutes, i.e., before any
compounds were administered, was 132.5/103.67mmHg
(Figure 2(d)).
Blood pressure values measured in the EtOH group, LA
group, and LA+EtOH group at the endpoint of the experi-
ment were 102.33/69.33, 115.33/89.67, and 111.5/81.5,
respectively.
This means that in the presence of LA, the decrease in
blood pressure is smaller than in the group of rats receiving
only EtOH.
3.6. The Effect of Combined Disulfiram and Ethanol
Treatment on the Systolic and Diastolic Blood Pressure in
Rats. The combined DSF and EtOH treatment statistically
significantly reduced systolic and diastolic blood pressure
in rats. Blood pressure before administration of EtOH
was 110.33/84.67mmHg, while measured 30 minutes after
administration of EtOH was 82.33/54.87mmHg. However,
the pressure measured at t = 0 minutes, i.e., before any
compounds were administered, was 119.17/91.5mmHg
(Figure 2(e)).
Blood pressure values measured in the EtOH group, DSF
group, and DSF+EtOH group at the endpoint of the experi-
ment were 102.33/69.33, 105/72, and 82.33/54.87mmHg,
respectively.
This means that in the presence of DSF, the decrease in
blood pressure is bigger than in the group of rats receiving
only EtOH.
3.7. The Effect of Combined Lipoic Acid, Disulfiram, and
Ethanol Treatment on the Systolic and Diastolic Blood
Pressure in Rats. Blood pressure before administration of
EtOH was 101.33/72mmHg, while measured 30 minutes
after administration of EtOH was 100.87/67.67mmHg.
However, the pressure measured at t = 0 minutes, i.e., before
LA and DSF were administered, was 121.67/98.33mmHg
(Figure 2(f)).
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Figure 1: The effect of 0.9% NaCl or EtOH on the systolic and diastolic blood pressure (SBP and DBP, respectively) in rats measured for
30min. Each group comprised 6 animals (n = 6). Data are shown as the mean ± SEM. Significant vs. the blood pressure measured before
the administration of EtOH, i.e., at t = 0; ∗p < 0:05.
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Blood pressure values measured in the EtOH group,
LA group, DSF group, LA+DSF group, LA+EtOH group,
DSF+EtOH group, and LA+DSF+EtOH at the endpoint
of the experiment were 102.33/69.33, 115.33/89.67,
105/72, 104.67/63.33, 111.5/81.5, 82.33/54.87, and
100.87/67.67mmHg, respectively.
This means that the greatest reduction in blood pressure
occurs in the group of rats receiving DSF and EtOH
(82.33/54.87mmHg). However, in the group of animals,
which apart from DSF and EtOH also received LA, the
decrease in blood pressure was significantly smaller
(100.87/67.67mmHg).
Figure 3 shows changes in systolic (a) and diastolic (b)
blood pressure in all groups of rats which received EtOH.
Taken together, a statistically significant decrease in sys-
tolic and diastolic blood pressure vs. group receiving only
0.9% NaCl (control group) presented in Figure 1 was
observed in 3 groups: EtOH group, DSF+EtOH group,
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Figure 2: The effect of LA, DSF, and various combinations of these chemical compounds with EtOH on the systolic and diastolic blood
pressure (SBP and DBP, respectively) in rats. Each group comprised 6 animals (n = 6). Data are shown as the mean ± SEM. Significant vs.
the blood pressure measured at t = 0 minutes, i.e., before the administration of any drugs. ∗p < 0:05; ∗∗∗p < 0:001.
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and LA+DSF+EtOH group. The greatest drop in blood
pressure vs. group receiving 0.9% NaCl (control group)
was noted in EtOH-treated rats which were given DSF
30min before EtOH.
3.8. The Effect of Various Combinations of Ethanol, Lipoic
Acid, and Disulfiram on the Heart Rhythm Disturbances in
Rats and on the Activity of Aldehyde Dehydrogenase in the
Rat Liver. The obtained results are shown in Tables 1 and 2.
Bradycardia was seen in all groups of rats; however, in
EtOH-treated group (group A) and in the group treated with
EtOH 30min after LA and DSF administration (group F),
bradycardia affected 100% of animals. In the remaining
groups, 83.5% of rats exhibited bradycardia. It is noteworthy
that bradycardia occurred also in 83.5% of animals receiving
LA alone (group C). Moreover, in rats treated first with LA
and 30min later with EtOH (group B), bradycardia was seen
also in 83.5% of animals, which could suggest a protective
action of LA (Table 1).
Extrasystoles were observed in 50% of rats in the EtOH-
treated group (group A) and in 33.3% of rats in the group
treated with EtOH 30min after LA administration (group
B). It indicates that prior LA administration reduced the
number of animals in which extrasystoles were observed
(Table 1).
Atrioventricular blocks were observed in 16.7% of rats
receiving EtOH (group A) and in 16.7% of rats treated with
EtOH 30min after LA (group B). In this case, LA administra-
tion did not decrease the number of rats with this disturbance
(Table 1).
Deaths of animals were observed in four groups. In the
EtOH-treated group (group A), four animals died (66.7%),
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Figure 3: The changes in systolic (a) and diastolic (b) blood pressure in all groups of rats which received EtOH. Each group comprised 6
animals (n = 6). Data are shown as the mean ± SEM. Significant vs. group receiving 0.9% NaCl (control group); ∗p < 0:05; ∗∗∗p < 0:001.
6 Oxidative Medicine and Cellular Longevity
one at 5min and three at 10min after EtOH administration.
In the LA+EtOH group (group B), one animal died (16.7%)
10min after EtOH administration (at 40min of the experi-
ment, EtOH was administered 30min after LA treatment).
In the DSF+LA+EtOH group (group F), four animals died
(66.7%), two 10min after EtOH administration (at 40min
of the experiment) and two 20min after EtOH administra-
tion (at 50min of the experiment, EtOH was administered
30min after LA and DSF treatment). In the DSF+EtOH
group (group G), four animals died (66.7%) 10min after
EtOH administration (at 40min of the experiment, EtOH
was administered 30min after DSF).
Taken together, the results presented in Table 1 demon-
strated bradycardia in all tested animals (groups A-G), while
extrasystoles and atrioventricular blocks were observed only
in the group treated with EtOH alone (group A) and in
EtOH-treated rats which were given LA 30min before EtOH
(group B). Deaths of animals were observed in all EtOH-
treated groups, but the fewest animals died (one animal,
which corresponds to 16.7%) in the group of animals which
was treated with LA 30min prior to EtOH administration
(group B: LA+EtOH group).
The results presented in Table 2 indicated that the
administration of EtOH, LA, and DSF separately or jointly
affected the ALDH activity in the rat liver. A significant
decrease in the activity of the enzyme vs. group receiving
0.9% NaCl was observed in the all treatment groups.
4. Discussion
The obtained results indicated that the greatest blood pres-
sure drop was observed in the group administered EtOH
after DSF treatment (Figures 2(e) and 3). It is commonly
known that DSF has been used for over 70 years as an
alcohol-aversive agent in the treatment of alcoholism. By
inhibiting ALDH activity, DSF causes EtOH intolerance
due to poisoning with acetaldehyde. It causes a spectrum
of undesirable symptoms collectively called DSF-EtOH reac-
tion (DER). Prancheva et al. described a case of a 53-year-
old man in whom DER manifested as severe hypotension
(blood pressure was 35/20mmHg) accompanied by ischemic
stroke [13].
The present data demonstrated also that in this experi-
ment, a number of animals died in all EtOH-treated groups,
but the fewest animals died (one animal, which corresponds
to 16.7%) in the LA+EtOH group. The question arises why,
despite the relatively low dose of EtOH, 66.7% of the animals
died in the group that only received EtOH. It is assumed
that blood alcohol levels (BACs) exceeding 500mg% can
result in death in humans as a result of paralysis of respi-
ratory centers in the brain stem. On the other hand, there
are known cases when alcohol produced death in humans
at the values of BAC ranging from under 200mg% to over
600mg% [14, 15]. Why some people survive high BAC
and others do not is an open question. In our opinion,
it is similar in animals. Jones proposed to consider that
when examining deaths due to acute ethanol poisoning,
among all other factors, lady luck should not be forgotten [15].
The present data demonstrated also that mortality in the
group treated with DSF and then with EtOH (DSF+EtOH)
was 66.7% (and was the same as in the group administered
LA and DSF before EtOH (LA+DSF+EtOH)). Development
of cardiovascular collapse in patients with DER has been
described by many authors. Ho et al. reported a patient with
DER in whom initial volume resuscitation and dopamine
infusion failed to restore the BP and blood pressure returned
Table 1: The effect of various combinations of ethanol (EtOH), lipoic acid (LA), and disulfiram (DSF) on the heart rhythm disturbances and
mortality in rats.
Disorders
EtOH LA+EtOH LA DSF DSF+LA DSF+LA+EtOH DSF+EtOH
Group A Group B Group C Group D Group E Group F Group G
Extrasystoles 3min (50%) 30min (33.3%) None None None None None
Bradycardia 5min (100%) 40min (83.5%) 60min (83.5%) 20min (83.5%) 25min (83.5%) 30min (100%) 40min (83.5%)
Atrioventricular
blocks (min/%)
3/16.7
5/16.7
30/16.7
30/16.7 None None None None None
Death (min/%)
5/16.7
10/50
40/16.7 None None None
40/33.3
50/33.3
40/66.7
Each group comprised 6 animals (n = 6). Data are presented as a percentage of animals with the heart rhythm disturbances and mortality in rats.
Table 2: The effect of various combinations of ethanol (EtOH),
lipoic acid (LA), and disulfiram (DSF) on the aldehyde
dehydrogenase activity in the rat liver.
Treatment
Activity of ALDH in the rat liver
(IU/min/mg protein)
Group receiving NaCl 38:41 ± 5:00
EtOH group aaa,bbb18:075 ± 4:05c
LA (group I) aaa,b11:3 ± 4:44d
DSF (group II) aaa6:43 ± 1:37ddd
LA+DSF (group III) aaa,ccc6:75 ± 1:42ddd
LA+EtOH (group IV) aaa8:10 ± 2:66ddd
DSF+EtOH (group V) aaa6:56 ± 1:04ddd
LA+DSF+EtOH (group VI) aaa,ccc4:09 ± 2:00ddd
Data are shown as the mean ± standard deviation (SD) of 6 animals per
group (n = 6); aaap < 0:001 vs. group receiving 0.9% NaCl; bp < 0:05 and
bbbp < 0:001 vs. DSF group; cp < 0:05 and cccp < 0:001 vs. LA group,
dp < 0:05 and dddp < 0:001 vs. EtOH group.
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to normal range only after noradrenaline administration
[16]. A similar case was described by Milne and Parke [17].
The present results indicate that LA can partially attenuate
arrhythmia (extrasystoles and atrioventricular blocks)
induced by EtOH. Many literature data confirm that LA
exerts powerful protective effects in numerous cardiovascular
diseases [7, 18, 19].
The obtained results demonstrated also that all DSF-
treated groups of animals showed the reduced ALDH activity
in the liver which is obvious (Table 2). In addition, we
observed that EtOH given alone also inhibited ALDH activity
(Table 2). Despite the counter-intuitive nature of this discov-
ery, the result is consistent with some results obtained by
other authors [20–22]. On the other hand, the results indicat-
ing that LA is an inhibitor of ALDH activity turned out to be
very surprising (Table 2), the more so that our previous
observations in vitro indicated that the presence of LA or
DHLA had no effect on the activity of yeast ALDH. Those
observations demonstrated also that DHLA but not LA could
protect ALDH against DSF-induced blockade, while neither
LA nor DHLA were able to restore the ALDH activity when
it already had been inhibited by DSF [23]. However, it should
be noted that it is increasingly more frequently underlined
that biological effects of LA obtained in vitro often differ
from those observed in vivo which was largely unnoticed
until recently [24, 25]. Some authors highlighted that LA
could participate, like glutathione (GSH), in S-thiolation of
proteins and this process is perceived to be a molecular
“switch” decisive for intracellular redox status of thiols able
to control cellular metabolic pathways [25]. In the case of
GSH, the formation of a mixed disulfide (G-S-S-Protein)
usually leads to inhibition of the biological activity of the
protein [26].
The mammalian ALDH is a redox-sensitive protein, and
the cysteine sulfhydryl group in its active site plays an essen-
tial role in its activity. Therefore, it is possible that ALDH
forms a mixed disulfide with LA (LA-S-S-ALDH) which
leads to a decrease in its activity. However, the problem of
S-thiolation involving LA is still not well understood and
there is virtually no literature data while those that can be
found are based more on suppositions and deductions, and
not on hard scientific evidence. Therefore, it seems that this
direction of research is worthy of attention.
Taken together, the present results indicated that LA in
rats can attenuate cardiovascular disorders induced by the
administration of EtOH. In our opinion, it was caused by
the ability of LA to ameliorate the reductive stress which
occurs as a result of metabolic processes related to EtOH.
The reductive stress is a counterpart of oxidative stress
and is defined as an abnormal increase in reducing equiva-
lents. EtOH produces reductive stress since its metabolism
results in overproduction of NADH. A decrease in the
NAD+/NADH ratio causes a decline in the activity of oxido-
reductases (reductive stress), resulting in an altered meta-
bolic situation that might be the first insult leading towards
several pathologies [27]. NADH excess has many metabolic
consequences, of which suppression of the Krebs cycle
(tricarboxylic acid cycle (TCA cycle)) and the mitochondrial
respiratory chain seem the most important. It is known that
the TCA cycle together with the associated electron transport
systems plays a key role in energy production. Inhibition of
both TCA cycle and respiratory chain hinders energy gener-
ation from any compound, including EtOH. Thus, EtOH
insidiously “deceives” the body because NADH accumula-
tion and TCA cycle inhibition are signals of intracellular
energy abundance, whereas actually the body faces a signifi-
cant energy deficit. Furthermore, the elevated NADH levels
suppress synthesis of UDP-glucuronic acid (UDPGA) com-
pounds that must be attached to various xenobiotics (drugs,
poisons, dietary supplements, etc.) before they can be
excreted from the body.
Some researchers have observed that many degenerative
diseases are associated with a hypoxic state that results in
an increased NADH/NAD+ ratio [28, 29]. Many authors also
showed that reductive stress played an important role in the
development of cardiomyopathy in mice [30, 31]. In addi-
tion, overproduction of reducing equivalents imparted pleio-
tropic effects on gene expression, mitochondrial dysfunction
[32], and protein quality control [33] in cardiomyopathy
in mice.
It should be remembered that exogenous LA after admin-
istration is reduced to DHLA by NAD(P)H-dependent
enzymes which in a simplified form can be expressed as
LA +NADH +H+ ⟶DHLA +NAD+ ð3Þ
As a result of this reaction, NADH is oxidized to NAD,
and thus the NAD+/NADH ratio increases. Hence, it is a
plausible proposal that LA partially attenuated the toxicity
of EtOH by decreasing the reductive stress level. It is worth
noting that this is the first time when the novel hypothesis
was presented that LA, which is normally considered to be
an antioxidant, is also required for protection against reduc-
tive stress.
In conclusion, this study for the first time demonstrated
that LA could partially attenuate the cardiac arrhythmia
(extrasystoles and atrioventricular blocks) induced by EtOH
and reduced the EtOH-induced mortality of animals, which
supports a potential of LA for use in acute EtOH-
intoxication and suggests that further experiments are neces-
sary to elucidate the mechanism of action of LA as an
antidote to EtOH poisoning.
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